Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Health Topics: Page 3
Myrobalan Therapeutics completes $24M series A financing round
By
LabPulse.com staff writers
Biotech company Myrobalan Therapeutics completed a $24 million series A financing round Wednesday.
January 11, 2024
Gene therapy, companion diagnostic hit milestones for hemophilia A
By
Liz Carey
Six months after the FDA approved a one-time gene therapy for severe hemophilia A reportedly priced around $2.5 million per patient, the Center for Inherited Blood Disorders, a 340B treatment center in California, has announced the drug's first infusion.
January 11, 2024
Health Canada approves Pfizer’s hemophilia gene therapy
By
LabPulse.com staff writers
Health Canada, Canada’s regulatory agency, has approved Pfizer's Beqvez (fidanacogene elaparvovec) as a gene therapy treatment for adults with moderately severe to severe hemophilia B.
January 3, 2024
FDA approves test for opioid use disorder risk assessment
By
LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has approved a test designed to determine if a patient is at risk of developing opioid use disorder (OUD).
December 21, 2023
Bristol Myers Squibb acquires Karuna for $14B
By
LabPulse.com staff writers
Bristol Myers Squibb has made an agreement to buy biotech firm Karuna Therapeutics for $14 billion, an acquisition that gives the firm a promising experimental treatment for schizophrenia.
December 22, 2023
Sanford to launch rural precision medicine program in Upper Midwest
By
LabPulse.com staff writers
Sanford Health has announced a new genomics-based rural population health program in partnership with Helix.
December 15, 2023
Two new directions in Parkinson’s testing
By
Liz Carey
Two recent Parkinson’s announcements suggest a new biomarker test panel coming, as well as cell culture systems for studying Parkinson’s in the laboratory.
December 11, 2023
FDA approves CRISPR-based gene therapy, cell-based gene therapy for SCD
By
LabPulse.com staff writers
The FDA has approved Vertex Pharmaceuticals’ and CRISPR Therapeutics’ CRISPR-based gene-editing therapy for the treatment of VOCs in patients with sickle cell disease (SCD). It is the first CRISPR-based gene therapy to receive FDA approval.
December 8, 2023
King's College London, bit.bio collaboration launched to build multicell brain models
By
Matt Limb
A collaboration has been launched in the U.K. to build multicell models of the human brain deemed vital to develop novel therapies for neuronal and psychiatric disorders.
December 5, 2023
Potential drug target to prevent small vessel disease identified in study
By
Matt Limb
Scientists say lab-grown small blood vessels used in new disease models point to a theoretical potential treatment for a major cause of stroke and vascular dementia.
November 29, 2023
U.K. regulators approve 'world-first' sickle-cell gene therapy
By
Matt Limb
U.K. medical regulators have approved a “world-first” gene therapy that aims to cure two blood disorders: sickle cell disease and transfusion-dependent β-thalassemia. They are the first regulatory body to approve the treatment.
November 20, 2023
Networks of wearable sensors capture body sounds to improve patient monitoring
By
Nick Paul Taylor
Researchers have developed soft, miniaturized wearable devices to continuously capture the sounds of breathing and other bodily functions.
November 16, 2023
Previous Page
Page 3 of 69
Next Page